Back to Journals » Integrated Blood Pressure Control » Volume 14

Blood Pressure Control with Reference to Intensive Blood Pressure Targets Among Hypertension Patients on Chronic Follow-Up at Dessie Referral Hospital, Northeast Ethiopia

Authors Bogale K, Aderaw A

Received 22 October 2020

Accepted for publication 14 December 2020

Published 22 January 2021 Volume 2021:14 Pages 1—7

DOI https://doi.org/10.2147/IBPC.S268186

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Konstantinos Tziomalos


Kassahun Bogale,1 Assasu Aderaw2

1Clinical Pharmacy Unit, Department of Pharmacy, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia; 2Department of Pharmacy, Wollo University, Dessie, Ethiopia

Correspondence: Kassahun Bogale
Clinical Pharmacy Unit, Department of Pharmacy, College of Medicine and Health Sciences, Wollo University, PO Box: 1145, Dessie, Ethiopia
Tel +251-913290505
Fax +251-331190586
Email Kassahun.bogale@wu.edu.et

Background: Hypertension is a risk factor for heart, brain, kidney, and other diseases. It is also the major cause of premature death. Thus, it is important to prevent, treat, and control hypertension and to reduce the risk of cardiovascular disease.
Objective: To determine the level of blood pressure control and associated factors based on the new intensive blood pressure goals (< 130/80 mmHg).
Methods: A cross-sectional study design was used to assess the level of blood pressure control and associated factors from February 15 to April 15, 2019. Two hundred and sixteen patients were selected through a systematic sampling technique.
Results: From 203 hypertension patients incorporated in the study, 102 (50.2%) were females. The mean age of patients documented during the last date of follow-up was 55.2 (SD=± 14.47). About 51.2% of patients were less than 5 years from the day of diagnosis of hypertension. The majority of the study participants (111, 54.7%) were using two antihypertensives. The most common anti-hypertensive medication was hydrochlorothiazide (HCT), at 25 (12.3%). The most common combination drug therapy used was the combination of HCT and calcium channel blockers, at 62 (30.5%). Heart failure (22, 20.8%), stroke (18, 16.98%), and dyslipidemia (17, 16.04%) were the top three comorbidities. Based on the new intensive targets of blood pressure control (< 130/80 mmHg), the blood pressure was controlled for only 25 (12%) patients.
Conclusion: The level of blood pressure control for hypertensive patients on chronic follow-up at Dessie Referral Hospital was very poor.

Keywords: blood pressure control, Dessie Referral Hospital, hypertension

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]